Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 201 - 250 out of 28,383

Document Document Title
WO/2014/009521A1
The invention relates to a process for producing furfural and levulinic acid from lignocellulose-comprising biomass, said process comprising: (a) adding water and optionally an acid to said biomass to form a slurried biomass; (b) subject...  
WO/2014/008301A1
The invention provides new methods for the direct umpolung self-condensation of 5-hydroxymethylfurfural (HMF) by organocatalysis, thereby upgrading the readily available substrate into 5,5'-di(hydroxymethyl) furoin (DHMF). While many eff...  
WO/2014/008364A2
Biomass feedstocks (e.g., plant biomass, animal biomass, and municipal waste biomass) are processed to produce useful products, such as fuels. For example, systems are described that can convert feedstock materials to a sugar solution, w...  
WO/2014/007554A1
This invention provides a method of preparing a benzofuran derivative, which has industrial safety and high yield and may thus be viably applied to industrial mass production.  
WO/2014/002873A1
An organic EL element which has long service life and higher luminous efficiency and an aromatic amine derivative which enables such an organic EL element are provided by a specific aromatic amine derivative represented by formula (1) an...  
WO/2014/002967A1
Provided is a 4,6-hexadecadiene-2,4-dicarboxylic acid derivative or pharmaceutically acceptable salt thereof or the like, having anti-tumour activity and represented by general formula (I): [in the formula, R1 represents a hydroxy, –OR...  
WO/2014/003690A1
The disclosure provides the use of aryl or heteroaryl boronic acid in the preparation of 5-(hydroxymethyl)fufural (HMF) from saccharides. The aryl or heteroaryl boronic bearing electron-withdrawing groups on the aryl or heteroaryl ring o...  
WO/2013/192554A1
The compositions and methods described herein relate generally to substituted tropolone derivatives, which, among other features, are useful as histone deacetylase (HDAC) inhibitors.  
WO/2013/191940A1
Disclosed is a process to produce a purified vapor comprising dialkyl- furan-2,5-dicarboxylate (DAFD). Furan-2,5-dicarboxylic acid (FDCA) and an alcohol in an esterification zone to generate a crude diester stream containing dialkyl fura...  
WO/2013/188996A1
The present invention provides an application of Inula lineariifolia lactone A in the preparation of a medicine for treating a myocarditis. The Inula lineariifolia lactone A has a structure shown in a formula (I). In an animal medicine e...  
WO/2013/189950A1
Disclosed are dibenzofuran derivatives of usnic acid, compositions thereof and use thereof in dermatological or cosmetic formularions with antimicrobial, regenerative and anti-aging purposes.  
WO/2013/191944A1
A process to produce a dry purified furan-2,5-dicarboxylic acid (FDCA) is described. After oxidation of 5-(hydroxymethyl)furfural (5-HMF), a crude FDCA stream is produced that is fed to a crystallization zone followed by a solid-liquid d...  
WO/2013/189237A1
Disclosed are a novel andrographolide derivative and analogue as well as a preparation method of the novel andrographolide derivative and analogue and an application to the treatment, the prevention and the relief on human viruses and ne...  
WO/2013/191943A1
A process for purifying a crude furan 2,5-dicarboxylic acid composition (cFDCA) by hydrogenation of a FDCA composition dissolved in a hydrogenation solvent such as water, and hydrogenating under mild conditions, such as at a temperature ...  
WO/2013/191942A1
A process to produce a purified dimethyl-furan-2,5-dicarboxylate (DMFD) by feeding furan dicarboxylic acid and methanol to an esterification zone to generate a crude diester composition, and purifying the crude diester composition with a...  
WO/2013/190482A1
The present invention relates to a compound of formula (I): in which: Rdenotes a hydrogen atom or an acetyl group; and Ydenotes a radical chosen from OR' or NAR''; and their salts, their solvates and their optical isomers, their racemate...  
WO/2013/191938A1
A process for the manufacture of dialkyl furan-2,5-dicarboxylate (DAFD) vapor composition by feeding furan-2,5-dicarboxylic acid ("FDCA") to an esterification reactor and in the presence of an alcohol compound such as methanol, conductin...  
WO/2013/186550A1
A compound of formula (I): (I) wherein Y is, Z is OR10, NR11R11 SR11, S(0)R11 S02R11, R10 is H, optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally s...  
WO/2013/186203A3
A method of modifying the taste of a consumable, comprising adding to a consumable base at least one compound of the formula I in which (a) A is selected from the moieties (i) or (ii); (b) n is from 0-7, such that X is absent or a linear...  
WO/2013/188252A3
The diallyl ether derivatives of the cis and trans stereoisomers of 2,5-bis(hydroxymethyl)tetrahydrofuran are produced. These materials are expected to be useful for making a variety of biobased polymers. Processes are further described ...  
WO/2013/188480A1
Disclosed is a process to prepare a ribonolactone compound of Formula (I):[PLEASE INSERT CHEMICAL STRUCTURE HERE] comprising the step of reacting a fructosamine compound of Formula (II):[PLEASE INSERT CHEMICAL STRUCTURE HERE] in the pres...  
WO/2013/188252A2
The diallyl ether derivatives of the cis and trans stereoisomers of 2,5-bis(hydroxymethyl)tetrahydrofuran are produced. These materials are expected to be useful for making a variety of biobased polymers. Processes are further described ...  
WO/2013/185435A1
The present invention relates to an optical activity axially chiral α-allenic alcohol, a synthesis method and use thereof. A method of preparing a high optical activity chiral α-allenic alcohol by using propargyl alcohol, aldehyde and ...  
WO/2013/186203A2
A method of modifying the taste of a consumable, comprising adding to a consumable base at least one compound of the formula I in which (a) A is selected from the moieties (i) or (ii); (b) n is from 0-7, such that X is absent or a linear...  
WO/2013/182263A1
The invention relates to specific phenanthrenes, the use of the compound in an electronic device, and an electronic device containing at least one of said compounds. The invention further relates to a method for producing the compound an...  
WO/2013/184202A1
The present application discloses benzathine and related compounds and their use as FBXO-3 inhibitors.  
WO/2013/183380A1
The present invention relates to: provision of a method for producing an acrylic polymerizable monomer that can be used in various applications such as optical materials, resist materials, coating materials and lamination materials; and ...  
WO/2013/182046A1
An organic electronic material having the structure of formula (I) or (II) as described below and an organic electroluminescent device are disclosed. The organic electroluminescent device possesses high electronic transmission and inject...  
WO/2013/181786A1
Provided in the present invention are various labdane diterpenoid compounds and derivatives thereof for use in preparation of a pharmaceutical composition for preventing or treating neurodegenerative diseases. Also provided in the presen...  
WO/2013/178337A1
The invention relates to a novel process for the preparation of dronedarone (I) and pharmaceutically acceptable salts thereof, which comprises reacting of compound of formula (IV) with compound of formula (VI) in a Grignard reaction, and...  
WO/2013/179309A1
The present invention relates to a new series of chemical compounds with a novel norneolignan skeleton (chemical formula I) possessing a biological activity on the central nervous system (CNS), especially memory-enhancing and acetylcholi...  
WO/2013/180140A1
The present invention provides a novel dihydroorotic acid dehydrogenase inhibitor that is applicable to various diseases. As an active ingredient, a compound represented by formula (I) (wherein X represents a halogen atom; R1 represents ...  
WO/2013/175746A1
An organic electroluminescent element wherein between an opposing anode and cathode there is at least an organic light emission layer and an electron transport layer that are adjacent in this order from the anode side, the organic light ...  
WO/2013/177224A1
The invention provides novel compounds having the general formula (I) and pharmaceutically acceptable salts thereof, wherein the variables RA, subscript n, ring A, X2, L, subscript m, X1, B, R1, R2, R3, R4, R5 and RN have the meaning as ...  
WO/2013/174925A1
PATENT APPLICATION. TITLE: NEW STRIGOLACTONE ANALOGUES AND THE USE THEREOF FOR THE TREATMENT OF PLANTS. ABSTRACT: The invention concerns a compound with the general formula (I): (I) in which X represents O, S, NH or an N-alkyl radical, R...  
WO/2013/175211A1
The present invention relates to the prophylaxis of acute noise- induced hearing loss by administering a compound of formula (I): wherein: W is group (Wa), group (Wb) or group (Wc):  
WO/2013/177243A1
A process for making the compound of Formula I utilizes the starting compound, together with sulfilimine and sulfoxide process steps later on.  
WO/2013/170694A1
The present invention relates to a compound as represented by formula (I), pharmaceutical composition thereof as well as preparation method and uses thereof, in particular to the uses of the compound as represented by formula (I) for tre...  
WO/2013/172239A1
The present invention is an acid diffusion control agent consisting of at least one compound selected from among the group consisting of a compound represented by formula (1) and a compound represented by formula (2). In formula (1), R2 ...  
WO/2013/171332A3
The present invention relates to tertiary amines of formula (I) for use in therapy, particularly for use in treating cardiovascular disorders. The compounds have been found to regulate phospholamban phosphorylation by interfering with th...  
WO/2013/168048A1
Phenacene compounds of formula (I) are disclosed. All the variables in the formula are the same as defined in the description. A thin film semiconductor comprising the above compounds, and a field effect transistor device, a photovoltaic...  
WO/2013/169651A9
A method of making an anti-Markovnikov addition product is carried out by reacting an acid with an alkene or alkyne in a dual catalyst reaction system to the exclusion of oxygen to produce said anti-Markovnikov addition product; the dual...  
WO/2013/169651A1
A method of making an anti-Markovnikov addition product is carried out by reacting an acid with an alkene or alkyne in a dual catalyst reaction system to the exclusion of oxygen to produce said anti-Markovnikov addition product; the dual...  
WO/2013/166618A1
The present invention discloses use of prodrug of 4,9-dihydroxy-naphtho[2,3-b]furan derivative for circumventing cancer multidrug resistance. The present invention also discloses use of prodrug of 4,9-dihydroxy-naphtho[2,3-b]furan deriva...  
WO/2013/164292A1
The present invention relates to compounds of general formula (I), wherein the groups R1, R2 and m are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activ...  
WO/2013/164729A1
Provided herein is an improved, commercially viable and industrially advantageous process for the preparation of a prostaglandin derivatives and intermediates thereof, in high yield and purity.  
WO/2013/158251A1
The invention relates to fluorinated compounds and their use in the field of pathological syndromes of the cardiovascular system. Novel fluorinated benzofuran derivatives of amiodarone and pharmaceutically acceptable salts or solvates th...  
WO/2013/156398A1
The present invention relates to novel processes for improved preparation of homofarnesol, especially of (3E,7E)-homofarnesol and homofarnesol preparations having an elevated content of (3E,7E)-homofarnesol (also referred to as all-E-hom...  
WO/2013/157528A1
Provided is a medicinal agent comprising a compound represented by general formula (1), a pharmaceutically acceptable salt of the compound or a solvate of the compound or the pharmaceutically acceptable salt. A compound represented by ge...  
WO/2013/156738A2
Lichesterinic acid and the derivatives of same as pigmentation inhibitors. The invention relates to the cosmetic use of a compound chosen from the compounds of formula (A) and the salts of same as an agent for depigmenting the skin and/o...  

Matches 201 - 250 out of 28,383